CN101618157B - 一种用于治疗秋燥感冒的药物组合物及其制备方法 - Google Patents
一种用于治疗秋燥感冒的药物组合物及其制备方法 Download PDFInfo
- Publication number
- CN101618157B CN101618157B CN2009101375102A CN200910137510A CN101618157B CN 101618157 B CN101618157 B CN 101618157B CN 2009101375102 A CN2009101375102 A CN 2009101375102A CN 200910137510 A CN200910137510 A CN 200910137510A CN 101618157 B CN101618157 B CN 101618157B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- pharmaceutical composition
- autumn
- granule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 72
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 239000000203 mixture Substances 0.000 title claims abstract description 18
- 229940079593 drug Drugs 0.000 title description 28
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 238000007796 conventional method Methods 0.000 claims abstract description 6
- 239000008187 granular material Substances 0.000 claims description 61
- 239000008194 pharmaceutical composition Substances 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 241000628997 Flos Species 0.000 claims description 14
- 210000000582 semen Anatomy 0.000 claims description 13
- 239000002775 capsule Substances 0.000 claims description 11
- 239000002671 adjuvant Substances 0.000 claims description 10
- 229920002472 Starch Polymers 0.000 claims description 9
- 239000008107 starch Substances 0.000 claims description 9
- 235000019698 starch Nutrition 0.000 claims description 9
- 229920001353 Dextrin Polymers 0.000 claims description 8
- 239000004375 Dextrin Substances 0.000 claims description 8
- 235000019425 dextrin Nutrition 0.000 claims description 8
- 239000000890 drug combination Substances 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 239000003826 tablet Substances 0.000 claims description 7
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical group [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 5
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000005469 granulation Methods 0.000 claims description 5
- 230000003179 granulation Effects 0.000 claims description 5
- 239000000314 lubricant Substances 0.000 claims description 5
- 229910052708 sodium Inorganic materials 0.000 claims description 5
- 239000011230 binding agent Substances 0.000 claims description 4
- 238000005352 clarification Methods 0.000 claims description 4
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims description 3
- 238000000576 coating method Methods 0.000 claims description 3
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 claims description 3
- 235000019359 magnesium stearate Nutrition 0.000 claims description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 3
- 241000212941 Glehnia Species 0.000 claims description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 2
- 239000008118 PEG 6000 Substances 0.000 claims description 2
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 claims description 2
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 claims description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- -1 hydroxypropyl Chemical group 0.000 claims description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 2
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 2
- 239000002002 slurry Substances 0.000 claims description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 34
- 239000000463 material Substances 0.000 abstract description 8
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 2
- 238000002156 mixing Methods 0.000 abstract description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 abstract 1
- 235000017491 Bambusa tulda Nutrition 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 241000935235 Fritillaria meleagris Species 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 229930195210 Ophiopogon Natural products 0.000 abstract 1
- 244000248557 Ophiopogon japonicus Species 0.000 abstract 1
- 241000244269 Peucedanum Species 0.000 abstract 1
- 244000082204 Phyllostachys viridis Species 0.000 abstract 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 abstract 1
- 244000018633 Prunus armeniaca Species 0.000 abstract 1
- 235000009827 Prunus armeniaca Nutrition 0.000 abstract 1
- 239000011425 bamboo Substances 0.000 abstract 1
- 238000005119 centrifugation Methods 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 43
- 238000012360 testing method Methods 0.000 description 31
- 241000700159 Rattus Species 0.000 description 22
- 210000004072 lung Anatomy 0.000 description 19
- 241001465754 Metazoa Species 0.000 description 16
- 241000699670 Mus sp. Species 0.000 description 16
- 230000037396 body weight Effects 0.000 description 15
- 208000024891 symptom Diseases 0.000 description 14
- 206010011224 Cough Diseases 0.000 description 13
- 206010022000 influenza Diseases 0.000 description 13
- 238000012109 statistical procedure Methods 0.000 description 12
- 206010037660 Pyrexia Diseases 0.000 description 11
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 230000008859 change Effects 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 230000010354 integration Effects 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 8
- 210000000056 organ Anatomy 0.000 description 8
- 241000207199 Citrus Species 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- 206010041349 Somnolence Diseases 0.000 description 7
- 241000209140 Triticum Species 0.000 description 7
- 235000021307 Triticum Nutrition 0.000 description 7
- 235000020971 citrus fruits Nutrition 0.000 description 7
- 210000000265 leukocyte Anatomy 0.000 description 7
- 230000003908 liver function Effects 0.000 description 7
- 239000008188 pellet Substances 0.000 description 7
- 208000026435 phlegm Diseases 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 230000036760 body temperature Effects 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 230000003907 kidney function Effects 0.000 description 6
- 208000011580 syndromic disease Diseases 0.000 description 6
- 230000000954 anitussive effect Effects 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 239000012567 medical material Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 238000009534 blood test Methods 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 230000008030 elimination Effects 0.000 description 4
- 238000003379 elimination reaction Methods 0.000 description 4
- 239000003172 expectorant agent Substances 0.000 description 4
- 230000003419 expectorant effect Effects 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 210000003714 granulocyte Anatomy 0.000 description 4
- 230000003448 neutrophilic effect Effects 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 238000012795 verification Methods 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 210000000436 anus Anatomy 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 229960004756 ethanol Drugs 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 230000003285 pharmacodynamic effect Effects 0.000 description 3
- 238000009522 phase III clinical trial Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000005057 refrigeration Methods 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 239000012085 test solution Substances 0.000 description 3
- 210000001550 testis Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 210000003437 trachea Anatomy 0.000 description 3
- 210000004291 uterus Anatomy 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 210000004100 adrenal gland Anatomy 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 229940124579 cold medicine Drugs 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000008017 Hypohidrosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 238000011887 Necropsy Methods 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 241001092500 Photinia x fraseri Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037544 Purging Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 208000018569 Respiratory Tract disease Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- ZFSFDELZPURLKD-UHFFFAOYSA-N azanium;hydroxide;hydrate Chemical compound N.O.O ZFSFDELZPURLKD-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- HISXILKLJLKINL-UHFFFAOYSA-N chloroform;ethyl acetate;propan-2-one Chemical compound CC(C)=O.ClC(Cl)Cl.CCOC(C)=O HISXILKLJLKINL-UHFFFAOYSA-N 0.000 description 1
- 231100000749 chronicity Toxicity 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 239000002254 cytotoxic agent Substances 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000012850 discrimination method Methods 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000012562 intraclass correlation Methods 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 229940074869 marquis Drugs 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- VBUNOIXRZNJNAD-UHFFFAOYSA-N ponazuril Chemical compound CC1=CC(N2C(N(C)C(=O)NC2=O)=O)=CC=C1OC1=CC=C(S(=O)(=O)C(F)(F)F)C=C1 VBUNOIXRZNJNAD-UHFFFAOYSA-N 0.000 description 1
- WINGFJQHCRYKRB-UHFFFAOYSA-L potassium;sodium;diiodide Chemical compound [Na+].[K+].[I-].[I-] WINGFJQHCRYKRB-UHFFFAOYSA-L 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000005182 tip of the tongue Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Abstract
Description
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009101375102A CN101618157B (zh) | 2009-04-28 | 2009-04-28 | 一种用于治疗秋燥感冒的药物组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009101375102A CN101618157B (zh) | 2009-04-28 | 2009-04-28 | 一种用于治疗秋燥感冒的药物组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101618157A CN101618157A (zh) | 2010-01-06 |
CN101618157B true CN101618157B (zh) | 2012-07-04 |
Family
ID=41511685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009101375102A Active CN101618157B (zh) | 2009-04-28 | 2009-04-28 | 一种用于治疗秋燥感冒的药物组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101618157B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110426486B (zh) * | 2019-08-01 | 2021-08-17 | 正大青春宝药业有限公司 | 中药制剂中浙麦冬的鉴别方法 |
-
2009
- 2009-04-28 CN CN2009101375102A patent/CN101618157B/zh active Active
Non-Patent Citations (1)
Title |
---|
国家药典委员会.中华人民共和国药典临床用药须知 中药卷.《中华人民共和国药典临床用药须知 中药卷》.人民卫生出版社,2005,(第1版),第231页. * |
Also Published As
Publication number | Publication date |
---|---|
CN101618157A (zh) | 2010-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109674958B (zh) | 一种具有降尿酸功效的中药组合物及其制备方法和应用 | |
CN100457139C (zh) | 一种双黄连注射液的制备方法及其成分检测方法 | |
CN101310751A (zh) | 一种具有益气养血作用的中药组合物及其制备方法和质量控制方法 | |
CN103705754B (zh) | 一种治疗系统性红斑狼疮的中药组合物 | |
CN101322810B (zh) | 一种治疗上呼吸道感染的药物组合物 | |
CN101856438B (zh) | 一种治疗婴幼儿哮喘的药物组合物及其制备方法和用途 | |
CN101874839A (zh) | 巴戟天总有效部位提取物及其制备方法和用途 | |
CN103272083B (zh) | 用于预防和/或治疗哮喘的药物组合物、其制备方法及用途 | |
CN100563630C (zh) | 用于治疗妇女月经不调中药制剂的制备方法 | |
CN117137998A (zh) | 一种用于治疗阴虚湿热型病毒性感染和肺结节的药物组合物及其制剂和应用 | |
CN107648479A (zh) | 一种用于治疗高血压的中药组方及其制品 | |
CN101618157B (zh) | 一种用于治疗秋燥感冒的药物组合物及其制备方法 | |
CN106310017B (zh) | 一种治疗弥漫性肺间质纤维化肺肾气虚证的中药颗粒 | |
CN100435817C (zh) | 一种治疗呼吸系统疾患的中药组合物及其制备方法 | |
CN102552440B (zh) | 一种平喘消炎药物及其制备方法和用途 | |
JP5265347B2 (ja) | 急性および慢性気管支炎を治療するための医薬を調合する際の魔芋(こんにゃく芋)およびその抽出物の利用 | |
CN102204956B (zh) | 一种用于中风恢复期的中药组合物及其制备方法 | |
CN105287921A (zh) | 治疗胃癌的药物组合物及其制备方法 | |
CN100534476C (zh) | 由板蓝根和射干制成的药物组合物及其制备方法和用途 | |
CN108704036A (zh) | 一种治疗痛风的复方中药制剂及其制备方法 | |
CN102727627A (zh) | 一种治疗心力衰竭的中药组合物及其制备方法和应用 | |
CN103356746A (zh) | 一种用于慢性支气管炎的中草药组合物及其质量控制法 | |
CN102188600B (zh) | 一种用于治疗气管炎的中药制剂及其制备方法 | |
CN102416147B (zh) | 一种治疗戒毒人员的躁狂症的药物组合物 | |
CN101658646B (zh) | 一种治疗暑热感冒的药物组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Leng Fangnan Inventor after: Jiang Yunxian Inventor after: He Xiaoxia Inventor after: Pan Ying Inventor after: Han Ling Inventor before: Leng Fangnan Inventor before: Jiang Yunxian Inventor before: He Xiaoxia Inventor before: Han Yuefu |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LENG FANGNAN JIANG YUNXIAN HE XIAOXIA HAN YUEFU TO: LENG FANGNAN JIANG YUNXIAN HE XIAOXIA PAN YING HAN LING |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: LIAONING HUARUN BENXI THIRD PHARMACEUTICAL CO., LT Free format text: FORMER NAME: LIAONING BENXI SANYAO CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 117004 medicine Park, Benxi economic and Technological Development Zone, Liaoning Patentee after: Liaoning Huarun Benxi Sanyao Co., Ltd. Patentee after: Wang Yongyan Patentee after: Benxi national proprietary Chinese Medicine Engineering Technology Research Center Address before: 117004 medicine Park, Benxi economic and Technological Development Zone, Liaoning Patentee before: Liaoning Benxi Third Pharmaceutical Co., Ltd. Patentee before: Wang Yongyan Patentee before: Benxi national proprietary Chinese Medicine Engineering Technology Research Center |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 117004 medicine Park, Benxi economic and Technological Development Zone, Liaoning Co-patentee after: Wang Yongyan Patentee after: Liaoning Huarun Benxi Sanyao Co., Ltd. Co-patentee after: Benxi National Chinese Patent Medicine Engineering Technology Research Center Co., Ltd. Address before: 117004 medicine Park, Benxi economic and Technological Development Zone, Liaoning Co-patentee before: Wang Yongyan Patentee before: Liaoning Huarun Benxi Sanyao Co., Ltd. Co-patentee before: Benxi National Engineering and Technology Research Center of Chinese Patent Medicine |